Nishimura Midori Filiz, Igawa Takuro, Gion Yuka, Tomita Sakura, Inoue Dai, Izumozaki Akira, Ubara Yoshifumi, Nishimura Yoshito, Yoshino Tadashi, Sato Yasuharu
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Division of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, Japan.
J Pers Med. 2020 Dec 10;10(4):269. doi: 10.3390/jpm10040269.
Plasma cell type idiopathic multicentric Castleman disease (PC-iMCD) occasionally manifests as parenchymal lung disease. This study aimed to elucidate the detailed clinicopathological features of lung lesions in PC-iMCD and compare the findings with those in immunoglobulin (Ig) G4-related disease (IgG4-RD), the most difficult differential diagnosis of PC-iMCD. We analyzed the clinicopathological findings and immunohistochemical expression patterns of interleukin-6 (IL-6) and Igs in lung specimens from 16 patients with PC-iMCD and 7 patients with IgG4-RD. Histologically, pulmonary PC-iMCD could not be differentiated from IgG4-RD based on lesion distribution patterns, the number of lymphoid follicles and obliterative vasculitis, or fibrosis types. The eosinophil count was higher in the IgG4-RD group than in the PC-iMCD group ( = 0.004). The IgG4/IgG-positive cell ratio was significantly higher in the IgG4-RD group ( < 0.001). The IgA-positive cell count and IL-6 expression intensity were higher in the PC-iMCD group than in the IgG4-RD group ( < 0.001). Based on these findings, we proposed a new diagnostic approach to differentiate lung lesions of PC-iMCD and IgG4-RD. Our approach can be utilized to stratify patients with suspected lung-dominant PC-iMCD to identify candidates for strong immunosuppressive treatment, including IL-6 blockade, at an early stage.
浆细胞型特发性多中心Castleman病(PC-iMCD)偶尔表现为实质性肺疾病。本研究旨在阐明PC-iMCD肺部病变的详细临床病理特征,并将结果与PC-iMCD最难鉴别的免疫球蛋白(Ig)G4相关疾病(IgG4-RD)进行比较。我们分析了16例PC-iMCD患者和7例IgG4-RD患者肺标本的临床病理结果以及白细胞介素-6(IL-6)和免疫球蛋白的免疫组化表达模式。组织学上,基于病变分布模式、淋巴滤泡数量、闭塞性血管炎或纤维化类型,肺部PC-iMCD无法与IgG4-RD区分开来。IgG4-RD组的嗜酸性粒细胞计数高于PC-iMCD组(P = 0.004)。IgG4-RD组的IgG4/IgG阳性细胞比率显著更高(P < 0.001)。PC-iMCD组的IgA阳性细胞计数和IL-6表达强度高于IgG4-RD组(P < 0.001)。基于这些发现,我们提出了一种区分PC-iMCD和IgG4-RD肺部病变的新诊断方法。我们的方法可用于对疑似以肺部为主的PC-iMCD患者进行分层,以便在早期识别出适合包括IL-6阻断在内的强效免疫抑制治疗的候选者。